|
|
Spring
2007
All lectures are at 10:00am in Room 10-250
May 1
Chemistry In Industry Seminar Series
Dr. Francis G. Fang, Senior Executive Director, Process Research/Process Development, Eisai Research Institute
Title: "Process Research on Natural Product Based New Drug Candidates" May 10
Chemistry In Industry Seminar Series
Dr. Mark T. Goulet, Executive Director, Drug Design & Optimization, Merck Research Laboratories-Boston
Title: "Discovery of Taranabant: A Novel Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity"
May 15
Chemistry In Industry Seminar Series
Dr. Christopher J. Burns, Vice President, Research, Protez Pharmaceutical
Title: "Allosteric Non-Nucleoside Inhibitors of Hepatitis C RNA Polymerase (NS5B) - The Road to HCV-796"
No seminars scheduled.
No seminars scheduled.
No seminars scheduled.
No seminars scheduled.
No seminars scheduled.
No seminars scheduled.
No seminars scheduled.
|
